Russman B S, Buncher C R, White M, Samaha F J, Iannaccone S T
Department of Pediatrics, University of Connecticut Medical School, Newington, USA.
Neurology. 1996 Oct;47(4):973-6. doi: 10.1212/wnl.47.4.973.
The course of spinal muscular atrophy (SMA) is not well established except for those patients whose age of onset is before 6 months and who achieve only "sit with support" as their maximum function (Werdnig-Hoffmann disease or SMA I). This study shows that there is another group of SMA patients whose age of onset and maximum function achieved can be used as prognostic guides. Fifty percent of SMA patients who could walk without assistance and whose onset was prior to age 2 years lost the ability to walk independently by age 12. Fifty percent of SMA patients who walked and whose onset was between 2 and 6 years of age lost walking ability by age 44 years. Fifty percent of SMA patients who could walk with assistance as their best function ever achieved lost this ability by age 7 years, unrelated to age of onset; none could walk with assistance after age 14 years. Seventy-five percent of SMA patients who developed the ability to sit independently as their best function were still sitting after age 7 years independent of age of onset; 50% of this group could sit independently after age 14 years. Eighty-five percent of SMA patients who could walk could not negotiate stairs without holding onto a rail. They could raise their hands above the head; however, as they lost walking ability, they lost this function as well. Only one SMA patient whose maximum function was sitting independently could get to the sitting position on his own. Only two of these patients could hold their hands above their heads. All patients with SMA lose function over time. This function loss occurs slowly and is related primarily to maximum function achieved; knowledge of age of onset provides helpful information, especially for predicting the loss of independent walking.
除了那些发病年龄在6个月之前且最大功能仅为“在支撑下坐立”(韦尔尼克 - 霍夫曼病或脊髓性肌萎缩症I型)的患者外,脊髓性肌萎缩症(SMA)的病程尚未完全明确。本研究表明,还有另一组SMA患者,其发病年龄和所达到的最大功能可作为预后指导。50%在2岁之前发病且能独立行走的SMA患者,到12岁时失去了独立行走的能力。50%在2至6岁之间发病且能行走的SMA患者,到44岁时失去了行走能力。50%功能最佳时能在辅助下行走的SMA患者,在7岁时失去了这种能力,与发病年龄无关;14岁之后无人能在辅助下行走。75%功能最佳时能独立坐立的SMA患者,在7岁之后仍能保持独立坐立,与发病年龄无关;该组中50%的患者在14岁之后仍能独立坐立。85%能行走的SMA患者不扶栏杆就无法上下楼梯。他们能将手举过头顶;然而,随着他们失去行走能力,也失去了这项功能。只有一名功能最佳时能独立坐立的SMA患者能够自行坐到坐位。这些患者中只有两人能将手举过头顶。所有SMA患者的功能都会随着时间推移而丧失。这种功能丧失进展缓慢,主要与所达到的最大功能有关;发病年龄的信息也有帮助,特别是对于预测独立行走能力的丧失。